tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
VRTX
Vertex Pharmaceuticals
RESEARCH TOOLSreports
Want to see VRTX full AI Analyst Report?

Vertex Pharmaceuticals (VRTX) Ratios

6,686 Followers

Vertex Pharmaceuticals Ratios

VRTX's free cash flow for Q1 2026 was $0.87. For the 2026 fiscal year, VRTX's free cash flow was decreased by $ and operating cash flow was $0.38. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.02 2.90 2.69 3.99 4.83
Quick Ratio
 2.57 2.46 2.35 3.78 4.66
Cash Ratio
 1.42 1.32 1.28 2.92 3.83
Solvency Ratio
 0.63 0.56 -0.05 0.74 0.82
Operating Cash Flow Ratio
 1.09 0.94 -0.14 1.00 1.51
Short-Term Operating Cash Flow Coverage
 0.00 43.86 -5.34 0.00 0.00
Net Current Asset Value
$ 4.61B$ 3.72B$ 3.47B$ 8.99B$ 9.00B
Leverage Ratios
Debt-to-Assets Ratio
 0.08 0.15 0.08 0.04 0.05
Debt-to-Equity Ratio
 0.10 0.21 0.11 0.05 0.06
Debt-to-Capital Ratio
 0.09 0.17 0.10 0.04 0.06
Long-Term Debt-to-Capital Ratio
 0.00 0.09 0.00 0.00 0.00
Financial Leverage Ratio
 1.37 1.40 1.37 1.29 1.30
Debt Service Coverage Ratio
 423.17 44.52 -2.42 87.19 64.33
Interest Coverage Ratio
 463.67 357.95 -7.61 86.89 78.60
Debt to Market Cap
 0.00 0.02 <0.01 0.00 0.00
Interest Debt Per Share
 7.86 15.24 6.91 3.31 3.73
Net Debt to EBITDA
 -0.68 -0.24 -5.80 -2.08 -2.17
Profitability Margins
Gross Profit Margin
86.28%85.03%86.11%87.21%87.90%
EBIT Margin
41.02%39.43%2.53%44.83%48.01%
EBITDA Margin
42.32%41.14%4.41%46.66%49.67%
Operating Profit Margin
38.97%39.43%-2.11%38.83%48.23%
Pretax Profit Margin
42.15%38.45%2.25%44.38%47.39%
Net Profit Margin
35.40%32.74%-4.86%36.68%37.20%
Continuous Operations Profit Margin
35.40%32.74%-4.86%36.68%37.20%
Net Income Per EBT
83.98%85.14%-215.53%82.64%78.49%
EBT Per EBIT
108.16%97.53%-106.70%114.30%98.26%
Return on Assets (ROA)
16.38%15.12%-2.38%15.92%18.30%
Return on Equity (ROE)
23.93%21.18%-3.26%20.59%23.88%
Return on Capital Employed (ROCE)
21.13%21.37%-1.23%19.98%27.95%
Return on Invested Capital (ROIC)
17.74%18.12%2.63%16.44%21.81%
Return on Tangible Assets
17.37%16.05%-2.60%17.40%20.18%
Earnings Yield
3.97%3.41%-0.52%3.45%4.49%
Efficiency Ratios
Receivables Turnover
 6.14 5.88 6.85 6.31 6.19
Payables Turnover
 3.44 3.91 3.71 3.46 3.55
Inventory Turnover
 0.95 1.07 1.27 1.71 2.35
Fixed Asset Turnover
 7.62 3.92 4.26 6.79 6.13
Asset Turnover
 0.46 0.46 0.49 0.43 0.49
Working Capital Turnover Ratio
 1.61 1.81 1.33 0.94 1.00
Cash Conversion Cycle
 336.80 309.50 242.28 165.94 111.89
Days of Sales Outstanding
 59.45 62.05 53.31 57.82 58.94
Days of Inventory Outstanding
 383.59 340.70 287.47 213.64 155.62
Days of Payables Outstanding
 106.24 93.25 98.49 105.52 102.68
Operating Cycle
 443.04 402.76 340.77 271.46 214.57
Cash Flow Ratios
Operating Cash Flow Per Share
 16.69 14.20 -1.91 13.73 16.13
Free Cash Flow Per Share
 14.60 12.49 -3.07 12.72 15.33
CapEx Per Share
 2.09 1.71 1.16 1.00 0.80
Free Cash Flow to Operating Cash Flow
 0.87 0.88 1.60 0.93 0.95
Dividend Paid and CapEx Coverage Ratio
 8.00 8.30 -1.65 13.69 20.18
Capital Expenditure Coverage Ratio
 8.00 8.30 -1.65 13.69 20.18
Operating Cash Flow Coverage Ratio
 2.13 0.94 -0.28 4.38 4.59
Operating Cash Flow to Sales Ratio
 0.35 0.30 -0.04 0.36 0.46
Free Cash Flow Yield
3.40%2.76%-0.76%3.13%5.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.54 29.32 -193.61 28.97 22.26
Price-to-Sales (P/S) Ratio
 9.38 9.60 9.41 10.62 8.28
Price-to-Book (P/B) Ratio
 5.95 6.21 6.32 5.96 5.32
Price-to-Free Cash Flow (P/FCF) Ratio
 30.99 36.30 -131.21 31.98 18.84
Price-to-Operating Cash Flow Ratio
 27.15 31.92 -210.51 29.64 17.91
Price-to-Earnings Growth (PEG) Ratio
 0.05 -0.03 1.69 3.48 0.52
Price-to-Fair Value
 5.95 6.21 6.32 5.96 5.32
Enterprise Value Multiple
 21.50 23.09 207.43 20.69 14.51
Enterprise Value
 105.58B 114.72B 100.88B 95.29B 64.35B
EV to EBITDA
 20.36 23.09 207.43 20.69 14.51
EV to Sales
 8.62 9.50 9.15 9.66 7.21
EV to Free Cash Flow
 28.46 35.92 -127.64 29.06 16.39
EV to Operating Cash Flow
 24.90 31.59 -204.78 26.94 15.58
Tangible Book Value Per Share
 70.27 67.08 56.29 60.74 47.72
Shareholders’ Equity Per Share
 76.20 73.00 63.73 68.22 54.33
Tax and Other Ratios
Effective Tax Rate
 0.16 0.15 3.16 0.17 0.22
Revenue Per Share
 48.23 47.22 42.80 38.30 34.87
Net Income Per Share
 17.07 15.46 -2.08 14.05 12.97
Tax Burden
 0.84 0.85 -2.16 0.83 0.78
Interest Burden
 1.03 0.98 0.89 0.99 0.99
Research & Development to Revenue
 0.32 0.31 0.33 0.32 0.30
SG&A to Revenue
 0.15 0.15 0.13 0.00 0.00
Stock-Based Compensation to Revenue
 0.06 0.00 0.06 0.06 0.06
Income Quality
 0.98 0.92 0.92 0.98 1.24
Currency in USD